Accordingly, we encourage the adoption of GLP-1RA plus SGLT2i combination therapy in patients with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or multiple risk factors for ASCVD (i.e., age 55 years, overweight/obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria)
Getting started begins with a clinical evaluation, available in person in Scarsdale, New York, and via telehealth for eligible patients across the New York, New Jersey, Connecticut, Florida, and California
It aids in the production of energy (ATP), and it helps make the oxygen-carrying protein hemoglobin in red blood cells, which also influences energy levels
357 This outcome may be attributed to the short treatment duration, which was insufficient to sustain beneficial hemodynamic effects
Contact Casey Law Offices, S.C., where experienced Ozempic attorneys are ready to help